A Phase 1/2 Trial of X4P-001 as Single Agent and in Combination with Axitinib in Patients with Advanced Renal Cell Carcinoma

Type of Cancer
Genito-Urinary

Site
Hackensack

Sponsor
X4 Pharmaceuticals

Protocol Number
X4P-001-RCCA

To Learn More Call
201-510-0910